| Dr David C Wei, MD, FACS | |
|
3288 Moanalua Rd, Honolulu, HI 96819-1469 | |
| (808) 432-0000 | |
| (808) 432-8241 |
| Full Name | Dr David C Wei |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 3288 Moanalua Rd, Honolulu, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184678401 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD11351 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr David C Wei, MD, FACS 3288 Moanalua Rd, Honolulu, HI 96819-1469 Ph: (808) 432-0000 | Dr David C Wei, MD, FACS 3288 Moanalua Rd, Honolulu, HI 96819-1469 Ph: (808) 432-0000 |
News Archive
The University of Bristol has been awarded £2.7 million by the Medical Research Council (MRC) to create a new research centre which will apply knowledge from genetic analyses to large-scale studies of the health of the population. These investigations will aim to find the factors that are causing disease, which can then be influenced to reduce risk.
The therapeutic monoclonal antibody CT-P59 binds to the RBD of SARS-CoV-2, the site of these three major mutations, which may therefore reduce the potency of this antibody against the P.1 lineage. In a new study, the neutralizing potency of this monoclonal antibody towards both wildtype and P.1 SARS-CoV-2 is investigated. The researchers found that the ability to bind with the virus is impeded by the mutations, resulting in reduced potency in vitro.
A survey led by a team of researchers at the University of Cincinnati Academic Health Center reports that the majority of Ohio's emergency department administrators and physicians are in support of the most recent state guidelines for prescribing opioids, but challenges still exist in implementation.
Teva Pharmaceutical Industries Ltd. announced today that it has completed its acquisition of Cephalon, Inc. The combined company will have a significant presence in over 60 countries and generated approximately $20 billion in revenues on a pro-forma basis for the twelve months ended June 2011.
› Verified 7 days ago
Dr. David Shu- An Chou, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1029 Kapahulu Ave, Suite 306, Honolulu, HI 96816 Phone: 808-218-7858 Fax: 808-218-7859 | |
Joseph Sterbis, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Urology Clinic, Honolulu, HI 96822 Phone: 808-433-2972 | |
Dr. Kent K. Teruya, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1329 Lusitana St Ste 508, Honolulu, HI 96813 Phone: 808-531-1511 | |
Sergei Tikhonenkov, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1329 Lusitana St, Suite 602, Honolulu, HI 96813 Phone: 808-522-5055 | |
Ann M Aspera, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
William Joseph Yarbrough Jr., MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1329 Lusitana St, Suite 602, Honolulu, HI 96813 Phone: 808-522-5055 Fax: 808-524-6306 |